#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study of ECI830, ribociclib, and fulvestrant in patients with advanced hormone receptor positive, HER2-negative breast cancer and advanced solid tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Denmark France Germany Italy Spain

  • A Study of CLDN6 CAR-T Cell Therapy With or Without CLDN6 RNA-LPX Vaccine in Patients With CLDN6-Positive Advanced Solid Tumors That Returned or Did Not Respond to Treatment

    Recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany The Netherlands Sweden

  • A Study of Sodium Selenite Followed by Chemotherapy in Patients with Advanced Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden

  • A study of DT-7012 alone and in combination with pembrolizumab in patients with advanced solid tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    France

  • A study to test the safety and effects of TLN-372 alone and with other cancer drugs in patients with advanced solid tumors with KRAS gene changes

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • A Study of MK-1084 Alone and Combined with Cetuximab for People with Advanced Solid Tumors that Have a KRAS G12C Gene Change

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark France Germany Greece Italy Norway +3

  • Study of BMS-986504 for patients with advanced or metastatic non-small cell lung cancer with homozygous MTAP deletion who have previously received treatment

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Poland Romania Spain +1

  • Study on the Safety and Effectiveness of GSK5733584 with Dostarlimab and Carboplatin for Patients with Advanced Gynecological Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark Finland France Germany Greece +6

  • Study on the Safety and Effects of BMS-986507 with Pembrolizumab and Osimertinib Mesylate in Adults with Advanced Solid Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy The Netherlands Spain

  • Study of ETX-19477 for Patients with Advanced Solid Tumors After Standard Treatment

    Recruiting

    2 1 1
    Investigated Drugs:
    France Italy Spain